» Articles » PMID: 35143564

GM-CSF Perturbs Cell Identity in Mouse Pre-implantation Embryos

Overview
Journal PLoS One
Date 2022 Feb 10
PMID 35143564
Authors
Affiliations
Soon will be listed here.
Abstract

Growth factors became attractive candidates for medium supplementation to further improve the quality of embryo culture and to mimic in vivo nutrition. Granulocyte macrophage colony-stimulating factor (GM-CSF) is a cytokine influencing the maternal-fetal interface and supporting placental development in mouse and human. It is expressed in epithelial cells of the endometrium under the regulation of estrogens. The factor is already in clinical use and a large clinical trial showed that, if supplemented to an embryo culture medium, it leads to increased survival of embryos, especially in women with previous miscarriages. Animal and cell culture studies on isolated trophectoderm cells support an effect mainly on cellular expansion. Aim of this study was to investigate, if the supplementation of GM-CSF either in a human ART medium or in a mouse optimized medium, leads to a change in cell number and cell lineages in the early pre-implantation mouse embryo. Our data shows that mouse GM-CSF increased total cell numbers with increasing concentrations. This increase of cell number has not been found in embryos cultured in ART media with or without human GM-CSF (hGM-CSF) or in a mouse medium supplemented with different concentrations of hGM-CSF. The changes were caused by a marked difference in TE and primitive endoderm cell numbers but not due to a change in epiblast cell numbers. Additionally, results show an ectopic expression of NANOG among trophectoderm cells in both, human ART media (with and without GM-CSF) and at increasing concentrations in the mouse and the human GM-CSF supplemented media. In conclusion, we could show that GM-CSF has an effect on cell identity in mice, which might probably also occur in the human. Therefore, we would like to rare awareness that the use of supplements without proper research could bare risks for the embryo itself and probably also in the post-implantation phase.

Citing Articles

Good practice recommendations on add-ons in reproductive medicine†.

Lundin K, Bentzen J, Bozdag G, Ebner T, Harper J, Le Clef N Hum Reprod. 2023; 38(11):2062-2104.

PMID: 37747409 PMC: 10628516. DOI: 10.1093/humrep/dead184.


Culture conditions in the IVF laboratory: state of the ART and possible new directions.

Sciorio R, Rinaudo P J Assist Reprod Genet. 2023; 40(11):2591-2607.

PMID: 37725178 PMC: 10643723. DOI: 10.1007/s10815-023-02934-5.

References
1.
Sjoblom C, Wikland M, Robertson S . Granulocyte-macrophage colony-stimulating factor (GM-CSF) acts independently of the beta common subunit of the GM-CSF receptor to prevent inner cell mass apoptosis in human embryos. Biol Reprod. 2002; 67(6):1817-23. DOI: 10.1095/biolreprod.101.001503. View

2.
Rose R, Barry M, Dunstan E, Yuen S, Cameron L, Knight E . The BlastGen study: a randomized controlled trial of blastocyst media supplemented with granulocyte-macrophage colony-stimulating factor. Reprod Biomed Online. 2020; 40(5):645-652. DOI: 10.1016/j.rbmo.2020.01.011. View

3.
Boroviak T, Loos R, Lombard P, Okahara J, Behr R, Sasaki E . Lineage-Specific Profiling Delineates the Emergence and Progression of Naive Pluripotency in Mammalian Embryogenesis. Dev Cell. 2015; 35(3):366-82. PMC: 4643313. DOI: 10.1016/j.devcel.2015.10.011. View

4.
Rahmati M, Petitbarat M, Dubanchet S, Bensussan A, Chaouat G, Ledee N . Colony Stimulating Factors 1, 2, 3 and early pregnancy steps: from bench to bedside. J Reprod Immunol. 2015; 109:1-6. DOI: 10.1016/j.jri.2015.01.005. View

5.
Boiani M, Scholer H . Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol. 2005; 6(11):872-84. DOI: 10.1038/nrm1744. View